Physician profile
Mandeep Singh
NPI 1730392697
$5,882.22
in general payments reported to CMS, 2019-2025
28 companies · $808 in 2025
The $808 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $258 · 2021: $570 · 2022: $1,394 · 2023: $2,047 · 2024: $552 · 2025: $808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,605 · Travel and Lodging: $802.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,604.92 |
| Travel and Lodging | $801.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,610.95 | 2021-2024 | Axonics |
| Procept Biorobotics Corporation | $985.79 | 2023 | Aquabeam Robotic System |
| Boston Scientific Corporation | $490.93 | 2021-2025 | Axonics, Spaceoar Vue System - 10ml |
| Astellas Pharma US INC | $396.01 | 2019-2024 | Xtandi, Myrbetriq |
| Neotract INC. | $232.97 | 2019-2020 | |
| Olympus America INC. | $202.81 | 2022-2025 | Itind System |
| Sumitomo Pharma America, INC. | $121.74 | 2023-2025 | Gemtesa, Orgovyx |
| Urovant Sciences INC | $115.10 | 2021-2022 | |
| Janssen Biotech, INC. | $106.34 | 2019-2025 | Erleada |
| Teleflex LLC | $94.26 | 2021-2025 | Barrigel |
| Merck Sharp & Dohme LLC | $75.99 | 2020-2025 | Keytruda, Lynparza |
| Vertex Pharmaceuticals Incorporated | $58.49 | 2024-2025 | |
| Laborie Medical Technologies Corp. | $52.54 | 2021-2022 | |
| Myovant Sciences INC. | $40.26 | 2021-2022 | |
| Medtronic, INC. | $36.67 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Ih INC. | $30.20 | 2020 | |
| Dendreon Pharmaceuticals LLC | $27.28 | 2025 | Provenge |
| Abbvie INC. | $26.52 | 2023 | Botox |
| Immunitybio, INC. | $23.03 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $20.29 | 2025 | Caldolor |
| Photocure INC | $20.10 | 2020 | |
| Roche Diagnostics Corporation | $19.97 | 2019 | |
| Srs Medical Systems, INC. | $18.15 | 2024 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Becton, Dickinson and Company | $17.46 | 2023 | Bard Urinary Drainage Bag |
| Palette Life Sciences, INC. | $16.32 | 2022 | |
| Urogen Pharma, INC. | $15.52 | 2021 | |
| Endo Pharmaceuticals INC. | $14.08 | 2023 | Xiaflex |
| C. R. Bard, INC. & Subsidiaries | $12.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mandeep Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.